134 related articles for article (PubMed ID: 18781276)
1. Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer's disease.
Hsu WC; Wang HK; Lee LC; Fung HC; Lin JC; Hsu HP; Wu YR; Ro LS; Hu FJ; Chang YT; Lee-Chen GJ; Chen CM
J Neural Transm (Vienna); 2008 Nov; 115(11):1537-43. PubMed ID: 18781276
[TBL] [Abstract][Full Text] [Related]
2. HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan.
Chen CM; Wu YR; Hu FJ; Chen YC; Chuang TJ; Cheng YF; Lee-Chen GJ
Neurosci Lett; 2008 Apr; 435(3):219-22. PubMed ID: 18343577
[TBL] [Abstract][Full Text] [Related]
3. Association between HSPA5 Promoter Polymorphisms and a Reduced Risk of Normal Tension Glaucoma.
Lee CC; Wang TC; Wang HY; Hsu B; Shih RJ; Lo NW; Wang CY
Ophthalmic Res; 2022; 65(4):474-480. PubMed ID: 35378534
[TBL] [Abstract][Full Text] [Related]
4. Association of GRP78 promoter polymorphisms and serum GRP78 level with risk of asthenozoospermia.
Qin H; Wang R; Pang X; Wei Y; Yang F; Wang J
J Assist Reprod Genet; 2018 Dec; 35(12):2223-2231. PubMed ID: 30229503
[TBL] [Abstract][Full Text] [Related]
5. Association between Polymorphisms of Heat Shock Protein HSPA5 and Risk of Type 2 Diabetes Mellitus.
Klyosova EY; Azarova YE; Ilyina EA; Goryainova NV; Polonikov AV
Bull Exp Biol Med; 2024 Mar; 176(5):599-602. PubMed ID: 38724812
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in N-methyl-D-aspartate receptor subunit NR3A but not NR3B influences susceptibility to Alzheimer's disease.
Liu HP; Lin WY; Liu SH; Wang WF; Tsai CH; Wu BT; Wang CK; Tsai FJ
Dement Geriatr Cogn Disord; 2009; 28(6):521-7. PubMed ID: 20016182
[TBL] [Abstract][Full Text] [Related]
7. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
Wang JC; Kwon JM; Shah P; Morris JC; Goate A
Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease.
Athan ES; Lee JH; Arriaga A; Mayeux RP; Tycko B
Arch Neurol; 2002 Nov; 59(11):1793-9. PubMed ID: 12433268
[TBL] [Abstract][Full Text] [Related]
10. Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population.
Wang R; Qin HM; Qin L; Wei JX; Wei YX; Wang JL
Int J Clin Oncol; 2019 Apr; 24(4):359-365. PubMed ID: 30413914
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease.
Luedecking EK; DeKosky ST; Mehdi H; Ganguli M; Kamboh MI
Hum Genet; 2000 May; 106(5):565-9. PubMed ID: 10914688
[TBL] [Abstract][Full Text] [Related]
12. Activation profiles of HSPA5 during the glomerular mesangial cell stress response to chemical injury.
Falahatpisheh H; Nanez A; Montoya-Durango D; Qian Y; Tiffany-Castiglioni E; Ramos KS
Cell Stress Chaperones; 2007; 12(3):209-18. PubMed ID: 17915553
[TBL] [Abstract][Full Text] [Related]
13. Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population.
Liu S; Li K; Li T; Xiong X; Yao S; Chen Z; Wang C; Zhao B
DNA Cell Biol; 2013 Mar; 32(3):119-24. PubMed ID: 23402331
[TBL] [Abstract][Full Text] [Related]
14. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
17. The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma.
Zhu X; Zhang J; Fan W; Wang F; Yao H; Wang Z; Hou S; Tian Y; Fu W; Xie D; Zhu W; Long J; Wu L; Zheng X; Kung H; Zhou K; Lin MC; Luo H; Li D
Carcinogenesis; 2013 Jun; 34(6):1273-80. PubMed ID: 23416888
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia.
Wang HK; Hsu WC; Fung HC; Lin JC; Hsu HP; Wu YR; Hsu Y; Hu FJ; Lee-Chen GJ; Chen CM
Dement Geriatr Cogn Disord; 2007; 24(2):104-10. PubMed ID: 17622713
[TBL] [Abstract][Full Text] [Related]
19. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
20. Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.
Lambert JC; Luedecking-Zimmer E; Merrot S; Hayes A; Thaker U; Desai P; Houzet A; Hermant X; Cottel D; Pritchard A; Iwatsubo T; Pasquier F; Frigard B; Conneally PM; Chartier-Harlin MC; DeKosky ST; Lendon C; Mann D; Kamboh MI; Amouyel P
J Med Genet; 2003 Jun; 40(6):424-30. PubMed ID: 12807963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
